Jesse Gelsinger

244 ‒ The history of the cell, cell therapy, gene therapy, and more | Siddhartha Mukherjee

Peter Attia MD

A young patient who died at 18 during an early gene therapy trial in 1999 at the University of Pennsylvania, due to a severe immune response to the adenovirus vector used to correct an enzyme defect in his liver.